INS and diabetes mellitus: The majority of trials did not explicitly provide information on how diabetes was defined with the exception of four trials, in which T2D was defined as fasting plasma glucose ≥7 mmol/L [13,14,30] or the use of oral glucose-lowering agents or insulin [13,14,24,32].